These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
544 related articles for article (PubMed ID: 24196373)
1. Impact of the type of SERPINC1 mutation and subtype of antithrombin deficiency on the thrombotic phenotype in hereditary antithrombin deficiency. Luxembourg B; Pavlova A; Geisen C; Spannagl M; Bergmann F; Krause M; Alesci S; Seifried E; Lindhoff-Last E Thromb Haemost; 2014 Feb; 111(2):249-57. PubMed ID: 24196373 [TBL] [Abstract][Full Text] [Related]
2. Thrombotic risk according to SERPINC1 genotype in a large cohort of subjects with antithrombin inherited deficiency. Alhenc-Gelas M; Plu-Bureau G; Hugon-Rodin J; Picard V; Horellou MH; Thromb Haemost; 2017 Jun; 117(6):1040-1051. PubMed ID: 28300866 [TBL] [Abstract][Full Text] [Related]
3. Novel SERPINC1 missense mutation (Cys462Tyr) causes disruption of the 279Cys-462Cys disulfide bond and leads to type Ⅰ hereditary antithrombin deficiency. Zhang F; Gui Y; Lu Y; Liu D; Chen H; Qin X; Li S Clin Biochem; 2020 Nov; 85():38-42. PubMed ID: 32745482 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis and thrombotic manifestations of antithrombin deficiency in 15 unrelated Chinese patients. Ding Q; Wang M; Xu G; Ye X; Xi X; Yu T; Wang X; Wang H Thromb Res; 2013 Sep; 132(3):367-73. PubMed ID: 23932013 [TBL] [Abstract][Full Text] [Related]
5. Antithrombin heparin binding site deficiency: A challenging diagnosis of a not so benign thrombophilia. Orlando C; Heylen O; Lissens W; Jochmans K Thromb Res; 2015 Jun; 135(6):1179-85. PubMed ID: 25837307 [TBL] [Abstract][Full Text] [Related]
6. Antithrombin deficiency in three Japanese families: one novel and two reported point mutations in the antithrombin gene. Maruyama K; Morishita E; Karato M; Kadono T; Sekiya A; Goto Y; Sato T; Nomoto H; Omi W; Tsuzura S; Imai H; Asakura H; Ohtake S; Nakao S Thromb Res; 2013 Aug; 132(2):e118-23. PubMed ID: 23809926 [TBL] [Abstract][Full Text] [Related]
7. Subtypes of SERPINC1 mutations and the thrombotic phenotype of inherited antithrombin deficient individuals in Chinese Han population. Wang D; Cui G; Hu S; Wang DW Blood Cells Mol Dis; 2016 Nov; 62():38-41. PubMed ID: 27863268 [TBL] [Abstract][Full Text] [Related]
8. Circulating microparticles and the risk of thrombosis in inherited deficiencies of antithrombin, protein C and protein S. Campello E; Spiezia L; Radu CM; Bulato C; Gavasso S; Tormene D; Woodhams B; Dalla Valle F; Simioni P Thromb Haemost; 2016 Jan; 115(1):81-8. PubMed ID: 26354831 [TBL] [Abstract][Full Text] [Related]
9. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update. Rodgers GM Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of hereditary antithrombin mutations is higher than estimated in patients with thrombotic events. Fischer R; Sachs UJ; Heidinger KS; Eisenburger D; Kemkes-Matthes B Blood Coagul Fibrinolysis; 2013 Jun; 24(4):444-8. PubMed ID: 23429250 [TBL] [Abstract][Full Text] [Related]
12. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary thromboembolism associated with hereditary antithrombin III deficiency: A case report. Liu J; Wang Y; Rong C; Wang B; Liu X; Zhang W Medicine (Baltimore); 2024 Mar; 103(10):e37429. PubMed ID: 38457560 [TBL] [Abstract][Full Text] [Related]
14. Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency. de la Morena-Barrio ME; Antón AI; Martínez-Martínez I; Padilla J; Miñano A; Navarro-Fernández J; Águila S; López MF; Fontcuberta J; Vicente V; Corral J Thromb Haemost; 2012 Mar; 107(3):430-7. PubMed ID: 22234719 [TBL] [Abstract][Full Text] [Related]
15. The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism. Vikydal R; Korninger C; Kyrle PA; Niessner H; Pabinger I; Thaler E; Lechner K Thromb Haemost; 1985 Dec; 54(4):744-5. PubMed ID: 4089808 [TBL] [Abstract][Full Text] [Related]
17. Homozygous antithrombin deficiency type II (99 Leu to Phe mutation) and childhood thromboembolism. Kuhle S; Lane DA; Jochmanns K; Male C; Quehenberger P; Lechner K; Pabinger I Thromb Haemost; 2001 Oct; 86(4):1007-11. PubMed ID: 11686316 [TBL] [Abstract][Full Text] [Related]
18. Antithrombin deficiency and decreased protein C activity in a young man with venous thromboembolism: a case report. Wang D; Tian M; Cui G; Wang DW Front Med; 2018 Jun; 12(3):319-323. PubMed ID: 28861852 [TBL] [Abstract][Full Text] [Related]
19. c.1058C>T variant in the SERPINC1 gene is pathogenic for antithrombin deficiency. Kumar R; Dawson JE; Chan AK; Forman-Kay JD; Kahr WH; Williams S Br J Haematol; 2015 Jul; 170(1):123-5. PubMed ID: 25522812 [No Abstract] [Full Text] [Related]
20. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Mahmoodi BK; Brouwer JL; Veeger NJ; van der Meer J Circulation; 2008 Oct; 118(16):1659-67. PubMed ID: 18824642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]